What is the Projected CAGR value of the Invasive Fungal Infection Market?
The Invasive Fungal Infection Market is expected to grow at a high CAGR during 2023-2030.
Which region controlled the global market during 2023-2030?
North American Region Controls the Invasive Fungal Infection Market during 2023-2030.
Which is the fastest-growing region in the Invasive Fungal Infection Market?
Among all regions, Asia Pacific is the fastest-growing market share during the forecast period.
Who are the key players in the Invasive Fungal Infection Market?
Cidara, Basilea Pharmaceutica, Pfizer, GlaxoSmith Kline, Bayer AG, Abbott, Merck & Co., Astellas Pharma Inc., and Scynexis Inc.